A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 112, Issue 8, 2005, Pages 1102-1108

  Hamoda, Haitham ^a   Ashok, Premila W ^a   Flett, Gillian M M ^a   Templeton, Allan ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MIFEPRISTONE; MISOPROSTOL; ABORTIVE AGENT;

ABORTION; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DRUG EFFICACY; FATIGUE; FEMALE; GESTATIONAL AGE; HEADACHE; HOT FLUSH; HUMAN; MAJOR CLINICAL STUDY; NAUSEA; PATIENT SATISFACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SHIVERING; SIDE EFFECT; TASTE; VOMITING; ADOLESCENT; COMPARATIVE STUDY; DRUG COMBINATION; FIRST TRIMESTER PREGNANCY; INDUCED ABORTION; INTRAVAGINAL DRUG ADMINISTRATION; METHODOLOGY; ORAL DRUG ADMINISTRATION; PREGNANCY; SUBLINGUAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTIFACIENT AGENTS, STEROIDAL; ABORTION, INDUCED; ADMINISTRATION, INTRAVAGINAL; ADMINISTRATION, ORAL; ADMINISTRATION, SUBLINGUAL; ADOLESCENT; ADULT; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MIFEPRISTONE; MISOPROSTOL; PATIENT SATISFACTION; PREGNANCY; PREGNANCY TRIMESTER, FIRST; TREATMENT OUTCOME;

EID: 24344432437     PISSN: 14700328     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2005.00638.x     Document Type: Article

References (20)

1. Ashok PW, Templeton A, Wagaarachchi PT, Flett GM. Factors affecting the outcome of early medical abortion: a review of 4132 consecutive cases. Br J Obstet Gynaecol 2002;109(11):1281-1289.
2. Bartley J, Tong S, Everington D, Baird DT. Parity is a major determinant of success rate in medical abortion: a retrospective analysis of 3161 consecutive cases of early medical abortion treated with reduced doses of mifepristone and vaginal gemeprost. Contraception 2000;62(6):297-303.
3. Baird DT. Medical abortion in the first trimester. Best Pract Res Clin Obstet Gynaecol 2002;16(2):221-236.
4. Kulier R, Gulmezoglu AM, Hofmeyr GJ, Cheng LN, Campana A. Medical methods for first trimester abortion. Cochrane Database Syst Rev 2004;(1):CD002855.
5. Meckstroth KR, Darney PD. Prostaglandins for first-trimester termination. Best Pract Res Clin Obstet Gynaecol 2003;17(5):745-763.
6. Ashok PW, Kidd A, Flett GM, Fitzmaurice A, Graham W, Templeton A. A randomized comparison of medical abortion and surgical vacuum aspiration at 10-13 weeks gestation. Hum Reprod 2002;17(1):92-98.
7. El Refaey H, Rajasekar D, Abdalla M, Calder L, Templeton A. Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol. N Engl J Med 1995;332(15):983-987.
8. Ho PC, Ngai SW, Liu KL, Wong GC, Lee SW. Vaginal misoprostol compared with oral misoprostol in termination of second-trimester pregnancy. Obstet Gynecol 1997;90(5):735-738.
9. Tang OS, Miao BY, Lee SWH, Ho PC. Pilot study on the use of repeated doses of sublingual misoprostol in termination of pregnancy up to 12 weeks gestation: efficacy and acceptability. Hum Reprod 2002;17(3):654-658.
10. Tang OS, Ho PC. Pilot study on the use of sublingual misoprostol for medical abortion. Contraception 2001;64(5):315-317.
11. Hamoda H, Ashok PW, Dow J, Flett GM, Templeton A. A pilot study of mifepristone in combination with sublingual or vaginal misoprostol for medical termination of pregnancy up to 63 days gestation. Contraception 2003;68(5):335-338.
12. Robinson HP. Sonar measurement of fetal crown-rump length as means of assessing maturity in first trimester of pregnancy. BMJ 1973;4(5883):28-31.
13. Tang OS, Schweer H, Seyberth HW, Lee SWH, Ho PC. Pharmacokinetics of different routes of administration of misoprostol. Hum Reprod 2002;17(2):332-336.
14. Henshaw RC, Naji SA, Russell IT, Templeton AA. A comparison of medical abortion (using mifepristone and gemeprost) with surgical vacuum aspiration: efficacy and early medical sequelae. Hum Reprod 1994;9(11):2167-2172.
15. Belanger E, Melzack R, Lauzon P. Pain of first-trimester abortion: a study of psychosocial and medical predictors. Pain 1989;36(3):339-350.
16. Grossman D, Ellertson C, Grimes DA, Walker D. Routine follow-up visits after first-trimester induced abortion. Obstet Gynecol 2004;103(4):738-745.
17. Luise C, Jermy K, Collons WP, Bourne TH. Expectant management of incomplete, spontaneous first-trimester miscarriage: outcome according to initial ultrasound criteria and value of follow-up visits. Ultrasound Obstet Gynecol 2002;19(6):580-582.
18. Creinin MD, Harwood B, Guido RS, Fox MC, Zhang J. NICHD management of early pregnancy failure, trial. Endometrial thickness after misoprostol use for early pregnancy failure. Intern J Gynecol Obtset 2004;86(1):22-26.
19. Harwood B, Meckstroth KR, Mishell DR, Jain JK. Serum beta-human chorionic gonadotropin levels and endometrial thickness after medical abortion. Contraception 2001;63(5):255-256.
20. Tang OS, Chan CC, Ng EH, Lee SW, Ho PC. A prospective, randomized, placebo-controlled trial on the use of mifepristone with sublingual or vaginal misoprostol for medical abortions of less than 9 weeks gestation. Hum Reprod 2003;18(11):2315-2318.